Barry Manilow's Lung Cancer: When It's Found Early

What Barry Manilow announced

On December 22, 2025, Barry Manilow posted a statement saying he had lung cancer. He was 82. He explained how it was found: he had bronchitis twice, for several weeks each time, and his doctor ordered an MRI as a precaution.

"The MRI discovered a cancerous spot on my left lung that needs to be removed," he wrote. "It's pure luck (and a great doctor) that it was found so early. The doctors do not believe it has spread, and I'm taking tests to confirm their diagnosis."

On his own website he added: "Ironically, I feel great and have no symptoms. I'm thankful that my doctors were proactive and ran tests that typically wouldn't be done. They caught it very, very early." The statement said he would have surgery in late December, followed by about a month of recovery, and that ten January arena concerts were moving to March and April.

He also had a message for fans: "If you have even the slightest symptom, get tested!"

That is what he disclosed. His stage, his tumor type and how his treatment went are not public, and this page does not guess. What follows is about lung cancer.

Two families of lung cancer

Doctors divide lung cancer into two broad groups, and the split drives treatment.

Non-small cell lung cancer, or NSCLC, is the large majority. Its main subtypes are adenocarcinoma, about 40 percent of lung cancers, and squamous cell carcinoma, about 25 percent. Squamous cell carcinoma usually starts near a central airway and is tied most strongly to smoking. Adenocarcinoma usually starts in the outer parts of the lung, and NCI notes it is found in people who never smoked.

Small cell lung cancer is the other group. It grows faster and is managed differently.

Why it is so often found late

The American Cancer Society projects 229,410 new lung and bronchus cancers in the United States in 2026 and 124,990 deaths, a forecast SEER, the federal cancer statistics program, carries alongside its own measurements. That is 20 percent of all cancer deaths, more than any other cancer.

The stage distribution explains much of it. Only 24 percent are found while the cancer is still confined to the lung. Twenty-one percent have reached nearby lymph nodes. Fifty-one percent have already spread to distant parts of the body by the time they are diagnosed.

Early lung cancer usually causes nothing at all. Manilow's own line, "I feel great and have no symptoms," is the ordinary case rather than the exception.

When to get checked

See a doctor about any of these:

• A cough that has lasted more than three weeks, or a long-standing cough that changes.
• Coughing up blood, even once.
• Chest pain that is worse with breathing or coughing.
• Breathlessness that is new for you, or a wheeze on one side.
• Repeated chest infections, or bronchitis that keeps coming back.
• Hoarseness lasting more than three weeks.
• Weight loss you did not intend, or unexplained tiredness.

Manilow's cancer surfaced through repeated bronchitis. Chest infections that keep returning in the same place are worth asking about, even when each one seems to clear.

What screening does, and who it is for

Low-dose CT is the only screening test shown to lower the risk of dying from lung cancer. NCI is specific about the evidence: chest x-rays and sputum cytology, in which coughed-up mucus is examined for cancer cells, do not.

The National Lung Screening Trial studied people aged 55 to 74 who had smoked at least a pack a day for 30 years or more, and who either still smoked or had quit within the previous 15 years. Yearly low-dose CT for three years beat chest x-ray at finding early lung cancer and cut the risk of dying from it.

Screening is not free of harm. NCI lists false-positive results, which can lead to procedures that turn out to be unnecessary, and overdiagnosis, meaning cancers found that would never have caused symptoms. Our page on lung cancer screening walks through who qualifies.

One point matters here. Manilow's tumor was found on an MRI ordered for a symptom, not by a screening program. That is not screening, and it does not change who screening is for.

What treatment involves for early disease

For stage I non-small cell lung cancer, NCI states plainly that surgery is the treatment of choice. The operation may be a lobectomy, which removes one lobe of the lung, or a smaller segmental, wedge or sleeve resection. Removing less tissue preserves more lung function, which matters when someone is already at risk of a second lung cancer.

The risks are real and are discussed in advance. NCI notes that death rates from lobectomy rise with age, with a 3 to 5 percent operative mortality rate expected. NCI also states that chemotherapy and radiation have not been shown to improve survival in stage I NSCLC that has been completely removed. Our overview of surgery for cancer covers what recovery generally involves.

The survival picture

Five-year relative survival across all stages of lung and bronchus cancer was 29.5 percent for people diagnosed from 2016 through 2022. About 5.2 percent of people are diagnosed at some point in life.

That single figure blends the 24 percent found early with the 51 percent found after spread, so it describes neither group well. It is a group statistic about people diagnosed years ago, and it does not forecast one person's course.

What this does not mean

Being lucky is not a plan. One tumor found by chance during a bronchitis workup does not mean chest imaging should be ordered for every cough, and NCI does not recommend that.

It also does not mean a symptom is nothing simply because most coughs are. The useful takeaway is Manilow's own: a symptom that persists is worth a conversation. Not smoking, and stopping if you do, remains the single largest thing anyone can do about lung cancer risk, which our guide to quitting smoking covers in practical terms.

Sources

• https://www.nbcnews.com/news/us-news/barry-manilow-reveals-lung-cancer-will-reschedule-shows-undergo-surger-rcna250498
• https://barrymanilow.com/barry-manilow-diagnosed-with-lung-cancer/
• https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq
• https://www.cancer.gov/types/lung/patient/lung-screening-pdq
• https://seer.cancer.gov/statfacts/html/lungb.html

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.